What is Merck & Co.'s deferred tax assets and other non-current assets?

Merck & Co. (MRK) reported deferred tax assets and other non-current assets of $19.81B in Q1 2026.

How has Merck & Co.'s deferred tax assets and other non-current assets changed year-over-year?

Merck & Co.'s deferred tax assets and other non-current assets increased by 18.1% year-over-year, from $16.77B to $19.81B.

What is the long-term trend for Merck & Co.'s deferred tax assets and other non-current assets?

Over 5 years (2020 to 2025), Merck & Co.'s deferred tax assets and other non-current assets has grown at a 10.7% compound annual growth rate (CAGR), from $743.00M to $1.24B.

What does deferred tax assets and other non-current assets mean?

The total value of long-term tax assets and other miscellaneous long-term assets.

Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets

Merck & Co. Deferred Tax Assets and Other Non-Current Assets increased by 1502.4% to $19.81B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 18.1%, from $16.77B to $19.81B. Over 5 years (FY 2020 to FY 2025), Deferred Tax Assets and Other Non-Current Assets shows an upward trend with a 10.7% CAGR.

Analysis

StatementBalance Sheet Statement

SectionNon-Current Assets

CategoryLiquidity

SignalContext dependent

VolatilityStable

First reportedQ4 2014

Last reportedQ1 2026May 4, 2026

How to read this metric

An increase generally reflects a growing long-term asset base or deferred tax position, while a decrease suggests asset liquidation or tax benefit utilization.

Detailed definition

This is the aggregate balance of non-current deferred tax assets and other miscellaneous non-current assets not classifi...

Peer comparison

Commonly found in the non-current asset section of balance sheets for large, diversified financial firms.

Metric ID: deferred_tax_assets_other_noncurrent

Historical Data

20 periods

	Q2 '21	Q3 '21	Q4 '21	Q1 '22	Q2 '22	Q3 '22	Q4 '22	Q1 '23	Q2 '23	Q3 '23	Q4 '23	Q1 '24	Q2 '24	Q3 '24	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Value	$11.05B	$11.19B	$434.00M	$11.14B	$10.97B	$9.58B	$520.00M	$10.28B	$10.19B	$10.56B	$755.00M	$12.33B	$12.70B	$14.44B	$802.00M	$16.77B	$17.66B	$18.33B	$1.24B	$19.81B
QoQ Change	—	+1.2%	-96.1%	>999%	-1.5%	-12.7%	-94.6%	>999%	-0.9%	+3.7%	-92.8%	>999%	+3.1%	+13.7%	-94.4%	>999%	+5.3%	+3.8%	-93.3%	>999%
YoY Change	—	—	—	—	-0.7%	-14.4%	+19.8%	-7.7%	-7.2%	+10.2%	+45.2%	+19.9%	+24.7%	+36.8%	+6.2%	+36.0%	+39.1%	+26.9%	+54.1%	+18.1%

Range$434.00M – $19.81B

CAGR+13.1%

Avg YoY Growth+19.2%

Median YoY Growth+19.9%

Deferred Tax Assets and Other Non-Current Assets at Other Companies

Bristol-Myers SquibbBMY View metric

PfizerPFE View metric

Regeneron PharmaceuticalsREGN View metric

United TherapeuticsUTHR View metric

ZoetisZTS View metric

Revolution Medicines, Inc.RVMD View metric

Frequently Asked Questions

What is Merck & Co.'s deferred tax assets and other non-current assets?: Merck & Co. (MRK) reported deferred tax assets and other non-current assets of $19.81B in Q1 2026.
How has Merck & Co.'s deferred tax assets and other non-current assets changed year-over-year?: Merck & Co.'s deferred tax assets and other non-current assets increased by 18.1% year-over-year, from $16.77B to $19.81B.
What is the long-term trend for Merck & Co.'s deferred tax assets and other non-current assets?: Over 5 years (2020 to 2025), Merck & Co.'s deferred tax assets and other non-current assets has grown at a 10.7% compound annual growth rate (CAGR), from $743.00M to $1.24B.
What does deferred tax assets and other non-current assets mean?: The total value of long-term tax assets and other miscellaneous long-term assets.